Description of event: protocol 13-005, pt.(b)(6), type 1a endoleak on zta-p-36-113, seen on 2 y fu.The patient was diagnosed with thoracic aortic aneurysm (taa) and that was the primary tevar indication.The patient had no symptoms and was categorized as an asa class 3 patient.Ct performed prior to study procedure revealed.The proximal neck diameter was 30 mm and the proximal neck length was 20 mm.Aneurysm maximum diameter was 55 mm.On (b)(6) 2017, during the index procedure, the patient received these cook devices: lot# e3594074 catalog# zta-p-36-113 proximal component.Lot# e3605725 catalog# zta-p-40-167 proximal component.The site indicated that delivery and deployment procedure was successful.The left subclavian artery (lsa) was intentionally completely covered by the stent graft fabric.The proximal zone of stent graft implantation was zone 2.The site performed an additional procedure of lsa occlusion by plug during the procedure.No reportable adverse events observed during the implant procedure.No endoleaks was left uncorrected.No evidence of false lumen perfusion.No evidence-collapse of proximal component.No additional technical observation.1-month fu: on (b)(6) 2017 (55 days post-procedure) the patient had a 1 month follow up ct scan performed.It revealed a maximum aneurysm diameter of 58 mm.A total length of covered aorta 192 mm.No technical observations/imaging abnormalities was observed on this imaging exam.2-year fu: on (b)(6) 2019 (662 days post-procedure) the patient had a 2 year follow up ct scan performed.The maximum aneurysm diameter was 54 mm and the total length of covered aorta 192 mm.The ct revealed a type 1a endoleak and the site indicated the location with following comment: proximal endoleak between left carotide artery and sub claviere artery.The site clarified in a query response that the endoleak type 1a was located on the zta-p-36-113 device.No evidence of stent graft migration.No evidence of collapse of the proximal component.No other technical observations/imaging abnormalities was observed on this imaging exam.Uns 1.On (b)(6) 2019 (666 days post-procedure) the patient had an event of an aneurysm.The event was not treated, and the site indicated that this was no sae (serious adverse event) with the following explanation: a secondary intervention should be necessary but the patients refused and is fragile.The site indicated that this event was not related to either study device or study procedure.Patient outcome: the patient remains in the study.
|